Jefferies & Co

Jefferies is out with an analyst note this morning, where they upgrade shares of Gibraltar Industries (NASDAQ: ROCK) to Buy from Hold; they have a $16.00 price target on the stock (revised upward from $13.00). The analysts said, “With the valuation now more reasonable and a number of positive...

Analysts at Jefferies & Co reiterate their "hold" rating on Monsanto (NYSE: MON). The target price for MON is set to $56. According to Jefferies & Co, “Over the next few weeks we expect newsflow as to Monsanto's initial price deck for the next U.S. planting season… Relative prices will...

Analysts at Jefferies & Co reiterate their "buy" rating on Under Armour (NYSE: UA), while raising their estimates for the company. The target price for UA is set to $40. According to Jefferies & Co, “Core apparel is trending well while footwear is on the mend with a series of new product...

Analysts at Jefferies & Co reiterate their "buy" rating on 3M (NYSE: MMM). The target price for MMM is set to $110. According to Jefferies & Co, 3M's business leaders argued for a nuanced and disciplined approach to developing "Tier B and C" products, where 3M can grow economic profits (and...

Jefferies & Co. is out with an analyst note this morning, where they reiterate their Buy rating on shares of Amylin Pharmaceuticals (NASDAQ: AMLN); they have a $31.00 price target. Jefferies analysts cited a recent Phase 3 trial of Roche's taspoglutide, which shows a clinical profile that will...

Jefferies & Co. is out with an analyst note this morning, where they reiterate their Buy rating on shares of Avon Products (NYSE: AVP); they have a $43.00 price target on the stock. Jefferies said, “We believe the recent currency devaluation in Venezuela will be about a -$0.07 per share drag...

Analysts at Jefferies & Co reiterate their "buy" rating on Invesco Ltd (NYSE: IVZ), while reducing their estimates for the company. The target price for IVZ is set to $25. The AUM in May was adversely impacted by the markets and currency fluctuations. Jefferies mentions, “Long-term investment...

Analysts at Jefferies & Co initiate coverage of Patterson Companies (NASDAQ: PDCO) with a "buy" rating. The target price for PDCO is set to $36. According to Jefferies, “Patterson should benefit from improving utilization in all three segments while remaining fairly immune to headline risks...

Jefferies & Co. has recently released its monthly report on the Mortgage and Housing segment. The report has maintained bullish sentiments, however, it also expressed concerns over sovereign debt issues impacting pricing for non-Agency RMBS and reinvestment risk in the Agency space. The report...

Amgen (Nasdaq: AMGN) will present at the Jeffries Global Life Sciences Conference at 6:00 a.m. Pacific Time on Wednesday, June 9, 2010, at the Grand Hyatt Hotel in New York City. Amgen's Roy Baynes, vice president of Global Development and Arvind Sood, vice president of Investor Relations will...

Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it...

Jefferies is out with an analyst note this morning where they reiterate their Buy rating on shares of Inverness Medical (NYSE: IMA); they have a $50.00 price target on the stock. Jefferies analysts cited their sum of the parts analysis, which showed that there is upside to IMA’s current valuation...

Jefferies is out with an analyst note this morning where they reiterate their Buy rating on shares of SAIC Inc. (NYSE: SAI); they have a $23.00 price target on the stock. Jefferies cited the company’s recent quarterly earnings report, where booking increased. They said, “Overall, we are encouraged...

Analysts at Jefferies & Co reiterate their "hold" rating on Immucor (NASDAQ: BLUD). The target price for BLUD is set to $21. BLUD announced its sales guidance for FY2011 slightly below and EPS forecasts in line with the estimates. “We expect the GM in FY11 to expand at a moderate pace given the...

Analysts at Jefferies & Co initiate coverage of Susser Holdings (NASDAQ: SUSS) with a "buy" rating. The target price for SUSS is set to $14. Jefferies & Co expects SUSS to deliver impressive EPS growth over the next 12 months as “pent-up benefits from its Town & Country acquisition in...